New saliva test can detect malaria before symptoms show
A new startup company is aiming to eliminate malaria with a rapid, early detection test that can identify the virus in saliva.
The SALVA! test works like blood-based malaria tests, with a test strip inside a plastic cassette, a little like a pregnancy test. The patient spits into a tube and the results are available within 5-20 minutes, without having to send the sample off to a lab.
It’s an easy test to administer as there’s no need for needles, therefore it doesn’t require trained clinicians and eliminates the fear children and adults may have of injections.
It can also detect the disease before symptoms appear which is crucial to treatment, as it can sometimes take up to two weeks for someone to show signs of the infection.
The test is the brainchild of Dr Benji Pretorius and Dr Richard Schmidt, two practicing doctors in South Africa who co-founded ERADA Technology Alliance in 2018, to put the test into production. They developed the SALVA! kit in collaboration with the Dinglasan Malaria Laboratory and John Hopkins University.
The test can also detect the proteins the parasite needs to survive. This would help the test remain effective long term as it will detect potential mutations of the virus. Further trials are currently on hold because of Covid-19.
There are around , according to the most recent figures from the WHO. An estimated 405,000 people died from the disease in 2018, and the health body has warned that almost half the world's population is at risk of contracting malaria. This warning is especially prescient now that most efforts are concentrated on controlling the Covid-19 pandemic.
Dr Pretorius recently wrote urging that work to combat malaria doesn’t stop because of the pandemic. “2020 was heralded as the year the global community stepped up its fight to eradicate malaria once and for all” he wrote. “Slowing death rates and mortality, coupled with advancements in detection and research, painted an encouraging picture. Now Covid-19 threatens to derail the significant progress we have made.
“Malaria still takes the lives of 400 000 people each year. Halting prevention programmes in order to concentrate efforts on Covid-19 will see that number almost double in the worst-case scenario, with sub-Saharan Africa being the hardest hit.
Additionally, many countries in the south of the country are approaching their rainy season, when we see the majority of malaria cases. All the components for a devastating spike in cases and mortality rates are aligning perilously close. Experts predict that, in the worst case scenario, we’ll see levels of cases and mortality rates last seen twenty years ago.
“It is imperative that the framework for malaria protection is in place and that it aligns with the latest Covid-19 guidance. This is not about choosing one disease to prevent over the other – it is about ensuring communities are prepared for both.”
Dr. Pretorius has specialised in treating malaria for most of his medical career. Recognising the harm it causes to education prospects as well as health, along with his own near-death experience from the disease, are what led him to co-founding ERADA.
- Ultra-fast Covid test could give results in under a minuteMedical Devices & Pharma
- PAMAfrica receives US$49mn to fight drug resistant malariaMedical Devices & Pharma
- The Bill & Melinda Gates Foundation launches a new non-profit biotech startupDigital Healthcare
- Novartis invests $100mn to research and develop next-generation antimalarialsDigital Healthcare